Bradley L. Schlaggar, MD, PhD

President & CEO Kennedy Krieger Institute / Hugo W. Moser Research Institute
Academic Rank: Professor of Neurology and Pediatrics Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Dr. Bradley L. Schlaggar (Honors ScB Brown University 1986; MD/PhD Washington University 1994) is the President & CEO of Kennedy Krieger Institute in Baltimore, MD, where he holds the Zanvyl Krieger Faculty Endowed Chair.  He is a Professor of Neurology and Pediatrics at Johns Hopkins University School of Medicine. Prior to moving to Baltimore in August 2018, Dr. Schlaggar was the A. Ernest and Jane G. Stein Professor of Developmental Neurology, in Neurology, and Professor of Neurology, Radiology, Neuroscience, Psychiatry, and Pediatrics, at Washington University in St. Louis School of Medicine. In 1999, he completed his pediatric neurology residency training at St. Louis Children’s Hospital and Washington University. From 2014-2018, he served as the Head of Pediatric & Developmental Neurology, co-Director of the Intellectual & Developmental Disabilities Research Center, and Neurologist-in-Chief at St. Louis Children’s Hospital. He served as the Pediatric Neurology Residency Director from 2005-2013. He has received numerous awards for research, mentorship, clinical care, and community service, including the Philip R Dodge Young Investigator Award from the Child Neurology Society, the Humanitarian Award from the Tourette Association of America, the Norman Geschwind Award for Behavioral Neurology from the American Academy of Neurology, the E. Mead Johnson Award from the Society for Pediatric Research, and the Frank Hatch Award for Outstanding Community Service from the John Merck Foundation.  Dr. Schlaggar’s research efforts, funded primarily by the NIH, are directed at understanding the development of the brain’s functional network architecture in typically and atypically developing children.  He has been deeply involved in the training of medical students, graduate students, fellows, and junior faculty. At Washington University, Dr. Schlaggar was the PI for the Neurological Sciences Academic Award (NSADA)-K12 for 10 years from 2008-2018.

Amy Brooks-Kayal, MD, FANA, FAES, FAAN

Title: Co-Director, CNCDP-K12 Professor & Chair Department of Neurology Andrew John Gabor, MD, PhD Presidential Endowed Chair University of California, Davis School of Medicine

Amy Brooks-Kayal, MD is a professor and the Chair of Neurology.  She joined UC Davis in October 2020 after 12 years as a Professor of Pediatrics, Neurology and Pharmaceutical Sciences, and Chief and Ponzio Family Chair of Pediatric Neurology at the University of Colorado School and Children's Hospital Colorado. Dr. Brooks-Kayal trained at Johns Hopkins University School of Medicine, University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP), then spent 13 years on the faculty at Penn/CHOP. Her area of clinical focus is pediatric epilepsy.  Her research focuses on regulation of gene expression during epileptogenesis. She is a Past President of the American Epilepsy Society, a past member of the NIH/NINDS Advisory Council and CURE Scientific Advisory Board, a member of the Commission on North American Affairs of the ILAE, a Director of the American Board of Psychiatry and Neurology, and a co-director of the national Child Neurology Career Development K12 program.


Barry E. Kosofsky, MD, PhD

Academic Rank: Chaired Professor (with tenure)
Weill Cornell Medical College/New York Presbyterian Hospital

Dr. Barry Kosofsky is the Horace W. Goldsmith Foundation Professor of Pediatrics, Pediatrics in Radiology, Neurology, and Neuroscience at Weill Cornell Medical Center, where he directs the Horace W. Goldsmith Foundation Laboratory of Molecular and Developmental Neuroscience. He is an Attending Pediatrician and Chief Emeritus of the Division of Pediatric Neurology at NewYork-Presbyterian/Komansky Children’s Hospital. He is Board Certified in Neurology with Special Competence in Child Neurology, and in Brain Injury Medicine. In addition to his clinical and administrative roles, Dr. Kosofsky is a clinician scientist who has developed and studied animal models of diseases which affect human brain development. The goal of his preclinical studies have been to gain mechanistic insights into such developmental brain disorders, as a starting point for improved diagnosis and potentially therapy for affected infants and children. This approach has included the use of sophisticated brain imaging methods as a foil for bi-directional translational research, which he has applied to the fields of gene therapy for neurogenetic disorders, autism, and traumatic brain injury in human subjects. The current focus of his research is identifying functional biomarkers predictive of ongoing symptoms following mild traumatic brain injury (mTBI). That effort includes the use of visual tracking, structural brain imaging, and functional assessments of vision, balance, and exercise tolerance. His research program now centers on the study of biomarkers of autonomic dysfunction, as a means of improving our ability to diagnose mTBI, and as a starting point for individualizing therapy for adolescents and adults with persistent post-concussive symptoms.

Dr. Kosofsky’s roles in the CNCDP are Executive Committee member and Retreat and Curriculum Oversight.

Erika F. Augustine, MD, MS

Associate Chief Science Officer, Director of the Clinical Trials Unit
Academic Rank: Associate Professor of Neurology, Johns Hopkins University

Kennedy Krieger Institute
707 North Broadway
Baltimore, MD 21205

Dr. Erika F. Augustine’s clinical research is focused on the development of new therapeutics in rare neurological diseases and includes FDA-funded research in Juvenile Batten Disease. She has also been active in programs to promote gender and racial diversity in medicine. Dr. Augustine, a practicing pediatric neurologist and movement disorders specialist, will direct activities supported by the grant to increase gender and racial diversity in the pediatric neurology research community. Specifically, she will focus on activities that in the short-term promote the awareness of NIH funded research opportunities among child neurologists of diverse backgrounds and over a long time-span increase awareness and interest in the field of Child Neurology as a whole.




Brenda Porter, MD, PhD

Academic Rank: Chief and Ponzio Family Chair in Pediatric Neurology
Professor of Pediatrics, Neurology and Pharmaceutical Sciences
The Stanford University Medical Center

Dr. Brenda Porter has clinical and research interests in pediatric epilepsy. Her current research is on tuberous sclerosis and other rare genetic epilepsies. She joined the CNCDPK12 due to a strong interest in mentoring and promoting the careers of pediatric neurologist with an interest in research. This includes working with funded scholars to ensure their success but also non-funded applicants to increase the utility of the CNCDPK12 retreat and other events for promoting career development and the research success of all early stage child neurologists.

Dr. Porter’s roles in the CNCDP are Executive Committee member and Mentorship of Scholars and Applicants.




Heather J. Fullerton, MD, MAS

Professor of Neurology and Pediatrics
Chief, Division of Child Neurology

Kenneth Rainin Chair of Pediatric Stroke Care
University of California, San Francisco

Dr. Heather Fullerton is a pediatric vascular neurologist with more than a decade’s experience leading NIH-funded multicenter clinical research studies in the field of stroke in the young. She is the Chief of Child Neurology at UCSF and enjoys fostering the career development of junior academic child neurologists. She is the founding president of the International Pediatric Stroke Organization (IPSO), a 501c3 non-profit that aims to bring together health providers of multiple disciplines from around the globe to improve the lives of children with cerebrovascular disease.

Dr. Fullerton’s roles in the CNCDP are Executive Committee member and leadership of the CNCDP Scholar Oversight Program.